NCT07162584 Oxytocin and Human Defensive Responses in a Dynamic Situation
| NCT ID | NCT07162584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Electronic Science and Technology of China |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-09-13 |
| Primary Completion | 2026-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-09-13 with a primary completion date of 2026-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The presnet study is to investigate the effect of intranasal oxytocin (24 IU) treatment on modulating how human responsd to threat in a dynamic situation.
Eligibility Criteria
Inclusion Criteria: * Healthy subjects without past or current psychiatric or neurological disorders Exclusion Criteria: * History of head injury; pregnant, menstruating, taking oral contraceptives; medical or psychiatric illness, * The presence of metal in the body or claustrophobia.
Contact & Investigator
Shuxia Yao, Dr
PRINCIPAL INVESTIGATOR
University of Electronic Science and Technology of China
Frequently Asked Questions
Who can join the NCT07162584 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07162584 currently recruiting?
Yes, NCT07162584 is actively recruiting participants. Contact the research team at k.kendrick.uestc@gmail.com for enrollment information.
Where is the NCT07162584 trial being conducted?
This trial is being conducted at Chengdu, China.
Who is sponsoring the NCT07162584 clinical trial?
NCT07162584 is sponsored by University of Electronic Science and Technology of China. The principal investigator is Shuxia Yao, Dr at University of Electronic Science and Technology of China. The trial plans to enroll 80 participants.